Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

1. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

   Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

   Шарҳ мақолаCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000011

2. Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

   Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5

   МақолаCAR-T cell therapy researchJournal of Hematology & Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000083